D.E. Shaw & Co
LUNG icon

D.E. Shaw & Co’s Pulmonx LUNG Stock Holding History

D.E. Shaw & Co’s Portfolio LUNG Stock Details LUNG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$432K Sell
335,074
-226,192
-40% -$374K ﹤0.01% 3924
2025
Q4 		$1.24M Sell
561,266
-227,983
-29% -$429K ﹤0.01% 3392
2025
Q3 		$1.28M Buy
789,249
+299,369
+61% +$626K ﹤0.01% 3299
2025
Q2 		$1.27M Buy
489,880
+3,325
+0.7% +$13.1K ﹤0.01% 3068
2025
Q1 		$3.27M Buy
486,555
+93,719
+24% +$664K ﹤0.01% 2222
2024
Q4 		$2.67M Buy
392,836
+32,049
+9% +$211K ﹤0.01% 2503
2024
Q3 		$2.99M Sell
360,787
-18,231
-5% -$132K ﹤0.01% 2379
2024
Q2 		$2.4M Sell
379,018
-52,279
-12% -$402K ﹤0.01% 2493
2024
Q1 		$4M Sell
431,297
-191,291
-31% -$2.24M ﹤0.01% 2063
2023
Q4 		$7.94M Sell
622,588
-45,770
-7% -$477K 0.01% 1547
2023
Q3 		$6.9M Sell
668,358
-48,020
-7% -$556K 0.01% 1551
2023
Q2 		$9.39M Buy
716,378
+142,214
+25% +$1.74M 0.01% 1390
2023
Q1 		$6.42M Buy
574,164
+320,174
+126% +$3.16M 0.01% 1734
2022
Q4 		$2.14M Buy
+253,990
New +$2.42M ﹤0.01% 2889
2021
Q2 		– Sell
-23,636
Closed -$1.08M – 4898
2021
Q1 		$1.08M Buy
+23,636
New +$1.36M ﹤0.01% 3053

Other funds holding LUNG

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ECM
ExodusPoint Capital Management New York $12.6B AUM 30.13% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

D.E. Shaw & Co's LUNG Position: Q1 2026 in Review

D.E. Shaw & Co reduced its Pulmonx (LUNG) stake by 40% in Q1 2026, selling an estimated $374K and leaving 335,074 shares worth $432K. The position accounts for ﹤0.01% of the portfolio, ranked #3924.

D.E. Shaw & Co first reported a position in LUNG in Q1 2021 and has held it in 15 quarters since. The position peaked at $9.39M in Q2 2023. 113 funds tracked by Wall St. Rank hold LUNG as of Q1 2026.

  • D.E. Shaw & Co held 335,074 shares of Pulmonx worth $432K as of Q1 2026.
  • D.E. Shaw & Co sold 226,192 Pulmonx shares in Q1 2026, an estimated $374K.
  • Pulmonx made up ﹤0.01% of D.E. Shaw & Co's portfolio in Q1 2026, its #3924 holding.
  • D.E. Shaw & Co first reported a position in Pulmonx in Q1 2021 and has held it in 15 quarters since.
  • D.E. Shaw & Co's Pulmonx position peaked at $9.39M in Q2 2023.
  • 113 funds tracked by Wall St. Rank held Pulmonx as of Q1 2026.

Based on D.E. Shaw & Co's 13F filing for Q1 2026, filed 15 May 2026.